Related Experiment Video
Updated: Aug 11, 2026
Implantation of Ferumoxides Labeled Human Mesenchymal Stem Cells in Cartilage Defects
Published on: April 5, 2010
Serum-Free Expanded Hair Follicle Mesenchymal Stem Cells Promote Cartilage Repair in a Murine Full-Thickness Defect
HaoChen Sun1, Emilie Gysel1, Leila Larijani2
1Department of Biomedical Engineering, Schulich School of Engineering, University of Calgary, Calgary, AB, Canada; McCaig Institute for Bone & Joint health, University of Calgary, Calgary, AB, Canada; Pharmaceutical Production Research Facility, Schulich School of Engineering, University of Calgary, Calgary, AB, Canada.
Serum-free expanded hair follicle mesenchymal stem cells (hfMSCs) effectively repaired cartilage defects in mice. These cells, expanded using static or stirred suspension bioreactors, promote healing primarily through secreted factors, not direct cell engraftment.
Area of Science:
- Regenerative Medicine
- Stem Cell Biology
- Biotechnology
Background:
- Osteoarthritis involves irreversible cartilage degeneration with limited self-repair.
- Current treatments manage symptoms, not cartilage restoration.
- Mesenchymal stem cell (MSC) therapies offer promise but face challenges in sourcing, variability, and scalable, serum-free manufacturing.
Purpose of the Study:
- To evaluate the efficacy of serum-free expanded hair follicle MSCs (hfMSCs) for cartilage repair.
- To compare static versus stirred suspension bioreactor (SSB) expansion methods for hfMSCs.
- To elucidate the mechanism of action for hfMSC-mediated cartilage repair.
Main Methods:
- Adapted hfMSCs to serum-free conditions and expanded them in static flasks or SSBs using microcarriers.
- Assessed MSC phenotype, multipotency (tri-lineage differentiation), and proteomic profiles.
- Evaluated cartilage repair in a murine model via intra-articular injection and histological analysis.
Main Results:
- Serum-free expansion in static or SSB formats maintained hfMSC phenotype, multipotency, and proliferation.
- Both expansion methods significantly improved histological cartilage repair compared to controls.
- Minimal direct hfMSC engraftment was observed, suggesting a paracrine mechanism supported by secreted proteins.
Conclusions:
- Serum-free expanded hfMSCs retain therapeutic potential for cartilage repair.
- Scalable bioreactor expansion is suitable for generating therapeutically competent hfMSCs.
- Further research is needed to standardize potency assays and investigate long-term efficacy and paracrine signaling.
